Last 12 months
Inside the activity.
0 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 7 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2022 Filed Sep 16, 2022 23:01 UTC |
MIRRO JUSTIN EDirector
|
ConversionClass B Ordinary Shares · Derivative | 9,857,142 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-031386 · doc4.xml · derivative · entry 7 MIRRO JUSTIN E · CIK 0001641982 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Common Stock · 9,857,142 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon completion of the Issuer's business combination transaction, the Issuer's Class B Ordinary Shares converted into shares of Common Stock of the Issuer. At the time the Class B shares were issued, the Issuer was a Cayman Islands exempted company incorporated with limited liability named "Kensington Capital Acquisition Corp. IV." In connection with a business combination transaction, the Issuer became a Delaware corporation and changed its name to "Amprius Technologies, Inc." F1 · derivative.exercise_date: Upon completion of the Issuer's business combination transaction, the Issuer's Class B Ordinary Shares converted into shares of Common Stock of the Issuer. At the time the Class B shares were issued, the Issuer was a Cayman Islands exempted company incorporated with limited liability named "Kensington Capital Acquisition Corp. IV." In connection with a business combination transaction, the Issuer became a Delaware corporation and changed its name to "Amprius Technologies, Inc." F1 · derivative.expiration_date: Upon completion of the Issuer's business combination transaction, the Issuer's Class B Ordinary Shares converted into shares of Common Stock of the Issuer. At the time the Class B shares were issued, the Issuer was a Cayman Islands exempted company incorporated with limited liability named "Kensington Capital Acquisition Corp. IV." In connection with a business combination transaction, the Issuer became a Delaware corporation and changed its name to "Amprius Technologies, Inc." F2 · ownership.nature: Prior to the liquidating distribution described in the note 3 below, the securities were owned by Kensington Capital Sponsor IV LLC (the "Sponsor"). The Reporting Person is the managing member of the managing member of the Sponsor. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 23:01 UTC |
MIRRO JUSTIN EDirector
|
OtherCommon Stock | 1,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-031386 · doc4.xml · nonDerivative · entry 6 MIRRO JUSTIN E · CIK 0001641982 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,000,000 F3 · kind: The securities were distributed in-kind, pro-rata and for no additional consideration to the members of the Sponsor in connection with its liquidating distribution. F3 · price: The securities were distributed in-kind, pro-rata and for no additional consideration to the members of the Sponsor in connection with its liquidating distribution. F7 · ownership.nature: The shares are owned by Elizabeth Mirro as trustee of the Kensington Capital Trust dated 6/27/20. Elizabeth Mirro is the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 23:01 UTC |
MIRRO JUSTIN EDirector
|
OtherCommon Stock | 1,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-031386 · doc4.xml · nonDerivative · entry 5 MIRRO JUSTIN E · CIK 0001641982 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,000,000 F3 · kind: The securities were distributed in-kind, pro-rata and for no additional consideration to the members of the Sponsor in connection with its liquidating distribution. F3 · price: The securities were distributed in-kind, pro-rata and for no additional consideration to the members of the Sponsor in connection with its liquidating distribution. F6 · ownership.nature: The shares are owned by the Reporting Person as trustee of the Justin E. Mirro 2020 Qualified Annuity Trust dated 6/27/20. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 23:01 UTC |
MIRRO JUSTIN EDirector
|
GrantCommon Stock | 111,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-031386 · doc4.xml · nonDerivative · entry 4 MIRRO JUSTIN E · CIK 0001641982 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,608,142 F5 · price: Acquired in a PIPE transaction that closed concurrently with the closing of the Issuer's business combination transaction on September 14, 2022. In the PIPE transaction, the Reporting Person acquired 111,000 shares of Common Stock and 111,000 PIPE Warrants (described in Table II) for an aggregate purchase price of $1,110,000. F4 · ownership.nature: The securities are owned by Kensington Capital Partners, LLC, of which the Reporting Person is the managing member. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 23:01 UTC |
MIRRO JUSTIN EDirector
|
OtherCommon Stock | 2,497,142 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-031386 · doc4.xml · nonDerivative · entry 3 MIRRO JUSTIN E · CIK 0001641982 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,497,142 F3 · kind: The securities were distributed in-kind, pro-rata and for no additional consideration to the members of the Sponsor in connection with its liquidating distribution. F3 · price: The securities were distributed in-kind, pro-rata and for no additional consideration to the members of the Sponsor in connection with its liquidating distribution. F4 · ownership.nature: The securities are owned by Kensington Capital Partners, LLC, of which the Reporting Person is the managing member. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 23:01 UTC |
MIRRO JUSTIN EDirector
|
OtherCommon Stock | 13,124,642 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-031386 · doc4.xml · nonDerivative · entry 2 MIRRO JUSTIN E · CIK 0001641982 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F3 · kind: The securities were distributed in-kind, pro-rata and for no additional consideration to the members of the Sponsor in connection with its liquidating distribution. F3 · price: The securities were distributed in-kind, pro-rata and for no additional consideration to the members of the Sponsor in connection with its liquidating distribution. F2 · ownership.nature: Prior to the liquidating distribution described in the note 3 below, the securities were owned by Kensington Capital Sponsor IV LLC (the "Sponsor"). The Reporting Person is the managing member of the managing member of the Sponsor. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 23:01 UTC |
MIRRO JUSTIN EDirector
|
ConversionCommon Stock | 9,857,142 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-031386 · doc4.xml · nonDerivative · entry 1 MIRRO JUSTIN E · CIK 0001641982 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 13,124,642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon completion of the Issuer's business combination transaction, the Issuer's Class B Ordinary Shares converted into shares of Common Stock of the Issuer. At the time the Class B shares were issued, the Issuer was a Cayman Islands exempted company incorporated with limited liability named "Kensington Capital Acquisition Corp. IV." In connection with a business combination transaction, the Issuer became a Delaware corporation and changed its name to "Amprius Technologies, Inc." F2 · ownership.nature: Prior to the liquidating distribution described in the note 3 below, the securities were owned by Kensington Capital Sponsor IV LLC (the "Sponsor"). The Reporting Person is the managing member of the managing member of the Sponsor. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 23:23 UTC |
Sun KangDirector · See Remarks
|
GrantStock Option (right to buy) · Derivative | 545,962 | Not disclosed Strike: $2.61 | Not disclosed |
DisclosureSEC source: 0000899243-22-031399 · doc4.xml · derivative · entry 4 Sun Kang · CIK 0001476220 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545,962 Underlying: Common Stock · 545,962 shares Expires 2032-04-13 F1 · price: On September 14, 2022, the Issuer completed a business combination (the "Business Combination") pursuant to the Business Combination Agreement, by and among the Issuer, a wholly owned subsidiary of the Issuer, and Amprius Technologies Operating, Inc. ("Legacy Amprius"). At the effective time of the Business Combination (the "Effective Time"), each Legacy Amprius option was converted into an option to purchase a number of shares of Common Stock of the Issuer equal to the product (rounded down to the nearest whole number) of (i) the number of shares of Legacy Amprius common stock subject to the Legacy Amprius option immediately prior to the Effective Time multiplied by (ii) an exchange ratio of approximately 1.45590 (the "Exchange Ratio"), at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such Legacy Amprius option immediately prior to the Effective Time divided by (B) the Exchange Ratio. F4 · derivative.exercise_date: 1/48 of the total number of shares issuable upon exercise of the option will vest on February 1, 2023, and 1/48 of the total number of shares issuable upon exercise of the option vest monthly thereafter until fully vested on January 1, 2027. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 23:23 UTC |
Sun KangDirector · See Remarks
|
GrantStock Option (right to buy) · Derivative | 727,950 | Not disclosed Strike: $2.61 | Not disclosed |
DisclosureSEC source: 0000899243-22-031399 · doc4.xml · derivative · entry 3 Sun Kang · CIK 0001476220 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 727,950 Underlying: Common Stock · 727,950 shares Expires 2032-04-13 F1 · price: On September 14, 2022, the Issuer completed a business combination (the "Business Combination") pursuant to the Business Combination Agreement, by and among the Issuer, a wholly owned subsidiary of the Issuer, and Amprius Technologies Operating, Inc. ("Legacy Amprius"). At the effective time of the Business Combination (the "Effective Time"), each Legacy Amprius option was converted into an option to purchase a number of shares of Common Stock of the Issuer equal to the product (rounded down to the nearest whole number) of (i) the number of shares of Legacy Amprius common stock subject to the Legacy Amprius option immediately prior to the Effective Time multiplied by (ii) an exchange ratio of approximately 1.45590 (the "Exchange Ratio"), at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such Legacy Amprius option immediately prior to the Effective Time divided by (B) the Exchange Ratio. F3 · derivative.exercise_date: 1/48 of the total number of shares issuable upon exercise of the option vested on February 1, 2022, and 1/48 of the total number of shares issuable upon exercise of the option vest monthly thereafter until fully vested on January 1, 2026. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 23:23 UTC |
Sun KangDirector · See Remarks
|
GrantStock Option (right to buy) · Derivative | 1,455,901 | Not disclosed Strike: $1.78 | Not disclosed |
DisclosureSEC source: 0000899243-22-031399 · doc4.xml · derivative · entry 2 Sun Kang · CIK 0001476220 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,455,901 Underlying: Common Stock · 1,455,901 shares Expires 2031-06-16 F1 · price: On September 14, 2022, the Issuer completed a business combination (the "Business Combination") pursuant to the Business Combination Agreement, by and among the Issuer, a wholly owned subsidiary of the Issuer, and Amprius Technologies Operating, Inc. ("Legacy Amprius"). At the effective time of the Business Combination (the "Effective Time"), each Legacy Amprius option was converted into an option to purchase a number of shares of Common Stock of the Issuer equal to the product (rounded down to the nearest whole number) of (i) the number of shares of Legacy Amprius common stock subject to the Legacy Amprius option immediately prior to the Effective Time multiplied by (ii) an exchange ratio of approximately 1.45590 (the "Exchange Ratio"), at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such Legacy Amprius option immediately prior to the Effective Time divided by (B) the Exchange Ratio. F2 · derivative.exercise_date: 1/48 of the total number of shares issuable upon exercise of the option vested on July 17, 2021, and 1/48 of the total number of shares issuable upon exercise of the option vest monthly thereafter until fully vested on June 17, 2025. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 23:23 UTC |
Sun KangDirector · See Remarks
|
GrantStock Option (right to buy) · Derivative | 727,950 | Not disclosed Strike: $0.05 | Not disclosed |
DisclosureSEC source: 0000899243-22-031399 · doc4.xml · derivative · entry 1 Sun Kang · CIK 0001476220 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 727,950 Underlying: Common Stock · 727,950 shares Expires 2024-03-15 F1 · price: On September 14, 2022, the Issuer completed a business combination (the "Business Combination") pursuant to the Business Combination Agreement, by and among the Issuer, a wholly owned subsidiary of the Issuer, and Amprius Technologies Operating, Inc. ("Legacy Amprius"). At the effective time of the Business Combination (the "Effective Time"), each Legacy Amprius option was converted into an option to purchase a number of shares of Common Stock of the Issuer equal to the product (rounded down to the nearest whole number) of (i) the number of shares of Legacy Amprius common stock subject to the Legacy Amprius option immediately prior to the Effective Time multiplied by (ii) an exchange ratio of approximately 1.45590 (the "Exchange Ratio"), at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such Legacy Amprius option immediately prior to the Effective Time divided by (B) the Exchange Ratio. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 23:20 UTC |
Chu StevenDirector
|
GrantStock Option (right to buy) · Derivative | 270,251 | Not disclosed Strike: $2.61 | Not disclosed |
DisclosureSEC source: 0000899243-22-031394 · doc4.xml · derivative · entry 2 Chu Steven · CIK 0001296381 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,251 Underlying: Common Stock · 270,251 shares Expires 2032-04-13 F2 · price: On September 14, 2022, the Issuer completed a business combination (the "Business Combination") pursuant to the Business Combination Agreement, by and among the Issuer, a wholly owned subsidiary of the Issuer, and Amprius Technologies Operating, Inc. ("Legacy Amprius") At the effective time of the Business Combination (the "Effective Time"), each Legacy Amprius option was converted into an option to purchase a number of shares of Common Stock of the Issuer equal to the product (rounded down to the nearest whole number) of (i) the number of shares of Legacy Amprius common stock subject to the Legacy Amprius option immediately prior to the Effective Time multiplied by (ii) an exchange ratio of approximately 1.45590, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such Legacy Amprius option immediately prior to the Effective Time divided by (B) the Exchange Ratio. F1 · derivative.exercise_date: 1/48 of the total number of shares issuable upon exercise of the option vested on February 1, 2022, and 1/48 of the total number of shares issuable upon exercise of the option vest monthly thereafter until fully vested on January 1, 2026. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 19:21 UTC |
Wallach SandraChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 145,590 | Not disclosed Strike: $2.61 | Not disclosed |
DisclosureSEC source: 0000899243-22-031395 · doc4.xml · derivative · entry 2 Wallach Sandra · CIK 0001698362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,590 Underlying: Common Stock · 145,590 shares Expires 2032-04-13 F2 · price: On September 14, 2022, the Issuer completed a business combination (the "Business Combination") pursuant to the Business Combination Agreement, by and among the Issuer, a wholly owned subsidiary of the Issuer, and Amprius Technologies Operating, Inc. ("Legacy Amprius") At the effective time of the Business Combination (the "Effective Time"), each Legacy Amprius option was converted into an option to purchase a number of shares of Common Stock of the Issuer equal to the product (rounded down to the nearest whole number) of (i) the number of shares of Legacy Amprius common stock subject to the Legacy Amprius option immediately prior to the Effective Time multiplied by (ii) an exchange ratio of approximately 1.45590, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such Legacy Amprius option immediately prior to the Effective Time divided by (B) the Exchange Ratio. F3 · derivative.exercise_date: 1/48 of the total number of shares issuable upon exercise of the option vested on February 1, 2023, and 1/48 of the total number of shares issuable upon exercise of the option vest monthly thereafter until fully vested on January 1, 2027. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 19:21 UTC |
Wallach SandraChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 582,360 | Not disclosed Strike: $1.78 | Not disclosed |
DisclosureSEC source: 0000899243-22-031395 · doc4.xml · derivative · entry 1 Wallach Sandra · CIK 0001698362 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 582,360 Underlying: Common Stock · 582,360 shares Expires 2031-08-22 F2 · price: On September 14, 2022, the Issuer completed a business combination (the "Business Combination") pursuant to the Business Combination Agreement, by and among the Issuer, a wholly owned subsidiary of the Issuer, and Amprius Technologies Operating, Inc. ("Legacy Amprius") At the effective time of the Business Combination (the "Effective Time"), each Legacy Amprius option was converted into an option to purchase a number of shares of Common Stock of the Issuer equal to the product (rounded down to the nearest whole number) of (i) the number of shares of Legacy Amprius common stock subject to the Legacy Amprius option immediately prior to the Effective Time multiplied by (ii) an exchange ratio of approximately 1.45590, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such Legacy Amprius option immediately prior to the Effective Time divided by (B) the Exchange Ratio. F1 · derivative.exercise_date: 1/4 of the total number of shares issuable upon exercise of the option vested on July 26, 2022, and 1/48 of the total number of shares issuable upon exercise of the option vest monthly thereafter until fully vested on July 26, 2025. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 23:29 UTC |
HSIEH Wen HsuanDirector
|
GrantStock Option (right to buy) · Derivative | 270,251 | Not disclosed Strike: $2.61 | Not disclosed |
DisclosureSEC source: 0000899243-22-031402 · doc4.xml · derivative · entry 2 HSIEH Wen Hsuan · CIK 0001835160 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,251 Underlying: Common Stock · 270,251 shares Expires 2032-04-13 F3 · price: On September 14, 2022, the Issuer completed a business combination (the "Business Combination") pursuant to the Business Combination Agreement, by and among the Issuer, a wholly owned subsidiary of the Issuer, and Amprius Technologies Operating, Inc. ("Legacy Amprius") At the effective time of the Business Combination (the "Effective Time"), each Legacy Amprius option was converted into an option to purchase a number of shares of Common Stock of the Issuer equal to the product (rounded down to the nearest whole number) of (i) the number of shares of Legacy Amprius common stock subject to the Legacy Amprius option immediately prior to the Effective Time multiplied by (ii) an exchange ratio of approximately 1.45590, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such Legacy Amprius option immediately prior to the Effective Time divided by (B) the Exchange Ratio. F2 · derivative.exercise_date: 1/48 of the total number of shares issuable upon exercise of the option vested on February 1, 2022, and 1/48 of the total number of shares issuable upon exercise of the option vest monthly thereafter until fully vested on January 1, 2026. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 23:20 UTC |
Bornstein JonathanChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 545,962 | Not disclosed Strike: $2.61 | Not disclosed |
DisclosureSEC source: 0000899243-22-031393 · doc4.xml · derivative · entry 2 Bornstein Jonathan · CIK 0001942459 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545,962 Underlying: Common Stock · 545,962 shares Expires 2032-04-12 F1 · price: On September 14, 2022, the Issuer completed a business combination (the "Business Combination") pursuant to the Business Combination Agreement, by and among the Issuer, a wholly owned subsidiary of the Issuer, and Amprius Technologies Operating, Inc. ("Legacy Amprius") At the effective time of the Business Combination (the "Effective Time"), each Legacy Amprius option was converted into an option to purchase a number of shares of Common Stock of the Issuer equal to the product (rounded down to the nearest whole number) of (i) the number of shares of Legacy Amprius common stock subject to the Legacy Amprius option immediately prior to the Effective Time multiplied by (ii) an exchange ratio of approximately 1.45590, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such Legacy Amprius option immediately prior to the Effective Time divided by (B) the Exchange Ratio F2 · derivative.exercise_date: 1/48 of the total number of shares issuable upon exercise of the option vested on February 1, 2023, and 1/48 of the total number of shares issuable upon exercise of the option vest monthly thereafter until fully vested on January 1, 2027. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 23:20 UTC |
Bornstein JonathanChief Operating Officer
|
GrantStock Option (right to buy) · Derivative | 2,183,851 | Not disclosed Strike: $0.05 | Not disclosed |
DisclosureSEC source: 0000899243-22-031393 · doc4.xml · derivative · entry 1 Bornstein Jonathan · CIK 0001942459 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,183,851 Underlying: Common Stock · 2,183,851 shares Expires 2024-03-15 F1 · price: On September 14, 2022, the Issuer completed a business combination (the "Business Combination") pursuant to the Business Combination Agreement, by and among the Issuer, a wholly owned subsidiary of the Issuer, and Amprius Technologies Operating, Inc. ("Legacy Amprius") At the effective time of the Business Combination (the "Effective Time"), each Legacy Amprius option was converted into an option to purchase a number of shares of Common Stock of the Issuer equal to the product (rounded down to the nearest whole number) of (i) the number of shares of Legacy Amprius common stock subject to the Legacy Amprius option immediately prior to the Effective Time multiplied by (ii) an exchange ratio of approximately 1.45590, at an exercise price per share (rounded up to the nearest whole cent) equal to (A) the exercise price per share of such Legacy Amprius option immediately prior to the Effective Time divided by (B) the Exchange Ratio Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.